Tag: BBM-P002

Medical illustration showing gene therapy delivery to brain regions affected by Parkinson's disease
Clinical UpdatesNew StudiesPracticeResearch Digest

First Dual-Target Gene Therapy for Parkinson’s Disease Shows Promise in Early Trial

First-in-human trial of BBM-P002 dual-target gene therapy shows sustained 12-month motor improvements in Parkinson's disease patients with excellent safety profile.…

By
GMJ Practice Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →